HeartBeam, Inc. (BEAT) Stock

HeartBeam, Inc. (BEAT) is a Healthcare stock trading at $0.75 (as of 2026-06-18), with a market capitalization of $48.74M and a trailing P/E of -1.4. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

HeartBeam, Inc. provides remote telehealth technology for detecting and monitoring cardiac disease outside traditional healthcare settings. Its system includes a portable single‑lead electrocardiogram device and cloud-based diagnostic software that generates information used by clinicians in managing patients with cardiovascular conditions.

Valuation — source: SEC EDGAR (first-party)
Price$0.75
Market Cap$48.74M
P/E Ratio-1.4
EV / EBITDA-2.0
Price / Book66.26
DCF Value (model)$-5.94
DCF Upside vs Price-891.9%
Profitability & Growth — source: SEC EDGAR
Return on Equity-3186.0%
Current Ratio0.74
Valuation vs Sector & Industry
Stock P/E-1.4
Sector P/E (Healthcare)21.0
Industry P/E (Medical Equipment)31.7
vs Sector-106.5%
vs Industry-104.3%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBlackRock Fund Advisors ($51.69M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEORobert Eno
Employees21
CountryUS
IPO Date2021-11-11

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • DarioHealth Corp. (DRIO)
  • InspireMD, Inc. (NSPR)
  • Prenetics Global Limited (PRE)
  • Plus Therapeutics, Inc. (PSTV)
  • Outset Medical, Inc. (OM)
  • Sensus Healthcare, Inc. (SRTS)
  • Nutriband Inc. (NTRB)
  • Modular Medical, Inc. (MODD)
BEAT earnings history · BEAT institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.